tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sean Lavin, 74 are a BUY (74.75%), 25 are a HOLD (25.25%).
Analyst Sean Lavin, currently employed at NOMURA, carries an average stock price target met ratio of 82.71% that have a potential upside of 27.24% achieved within 267 days.
Sean Lavin’s has documented 178 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MASI, Masimo at 26-Feb-2025.
Analyst best performing recommendations are on IRTC (IRHYTHM TECHNOLOGIES).
The best stock recommendation documented was for IRTC (IRHYTHM TECHNOLOGIES) at 11/14/2016. The price target of $28 was fulfilled within 4 days with a profit of $3.18 (12.81%) receiving and performance score of 32.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 15-Jul-2022
$380
$-1.02 (-0.27%)
$235
3 years 10 months 14 days ago
(02-Nov-2022)
1/2 (50%)
$6.49 (1.74%)
36
Buy Since 18-Jun-2021
$388
$6.98 (1.83%)
$355
3 years 10 months 14 days ago
(02-Nov-2022)
2/5 (40%)
$14.49 (3.88%)
88
Buy Since 22-Feb-2018
$380
$-1.02 (-0.27%)
$350
3 years 10 months 15 days ago
(01-Nov-2022)
24/41 (58.54%)
$2.18 (0.58%)
138
Buy Since 30-Jun-2021
$300
3 years 11 months 3 days ago
(13-Oct-2022)
1/3 (33.33%)
$57.23 (23.57%)
20
$330
$-47.78 (-12.65%)
4 years 5 months 10 days ago
(06-Apr-2022)
1/1 (100%)
$16.24 (5.18%)
209
What Year was the first public recommendation made by Sean Lavin?
